Breast Cancer Profiling Project, Drug Sensitivity phase I: Fixed-cell GR measures of 35 breast cell lines to 34 small molecule perturbagens from library plate I. Dataset 2 of 2: Calculated dose response metrics - Dataset (ID:20344)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Primary Target | Pathway | GR50 | GRmax | GR_AOC | Death_AUC | GR Hill Coefficient | GEC50 | GR r2 |
---|---|---|---|---|---|---|---|---|---|---|
SUM159PT | Volasertib | PLK | Cell cycle | 0.024832 | 0.0468 | 0.3873 | 0.1208 | 3.5660 | 0.024055 | 0.99966 |
CAL-85-1 | Luminespib | HSP90 | Misc | 0.006517 | -0.3836 | 0.7497 | 0.3002 | 4.8089 | 0.0073269 | 0.99963 |
SUM159PT | Vorinostat | HDAC | Misc | 1.9985 | 0.1195 | 0.1810 | 0.0216 | 1.3229 | 1.9352 | 0.99956 |
SUM149PT | Luminespib | HSP90 | Misc | 0.005116 | -0.3912 | 0.7555 | 0.3563 | 2.6742 | 0.0063272 | 0.99952 |
MDA-MB-361 | Luminespib | HSP90 | Misc | 0.0071417 | -0.8855 | 0.9781 | 0.3455 | 4.9987 | 0.0087421 | 0.9995 |
MCF7 | Dinaciclib | pan CDK | Cell cycle | 0.0083068 | -0.2493 | 0.6441 | 0.1256 | 3.5461 | 0.009348 | 0.9995 |
CAL-51 | Luminespib | HSP90 | Misc | 0.0063934 | -0.3386 | 0.7043 | 0.2784 | 3.0050 | 0.0075437 | 0.9995 |
SUM159PT | Dinaciclib | pan CDK | Cell cycle | 0.016967 | -0.0646 | 0.4536 | 0.1030 | 5.0000 | 0.017277 | 0.99948 |
MDA-MB-436 | Volasertib | PLK | Cell cycle | 0.0051788 | -0.1792 | 0.6616 | 0.1034 | 3.6059 | 0.0056092 | 0.99947 |
CAL-120 | Dinaciclib | pan CDK | Cell cycle | 0.009892 | -0.1320 | 0.5549 | 0.1203 | 4.4157 | 0.010404 | 0.99947 |
SUM149PT | Dinaciclib | pan CDK | Cell cycle | 0.013311 | -0.5676 | 0.6891 | 0.3611 | 4.0226 | 0.016068 | 0.99946 |
CAL-51 | Tivantinib | MET | RTK | 0.58755 | -0.2821 | 0.3592 | 0.1039 | 1.5478 | 0.80088 | 0.99945 |
SUM149PT | Buparlisib | pan PI3K | PI3K/mTOR | 1.4121 | -0.3357 | 0.2539 | 0.1216 | 1.9093 | 1.9133 | 0.99941 |
CAL-51 | Bleomycin | Radiation | Misc | 0.1694 | -0.1344 | 0.4855 | 0.0479 | 0.8490 | 0.24736 | 0.9994 |
CAL-51 | Dinaciclib | pan CDK | Cell cycle | 0.014709 | -0.3585 | 0.5985 | 0.2374 | 3.5319 | 0.017105 | 0.99939 |
MDA-MB-468 | Volasertib | PLK | Cell cycle | 0.002104 | -0.4485 | 0.9279 | 0.3934 | 2.9173 | 0.0026072 | 0.99938 |
SUM159PT | Neratinib | EGFR/HER2 | RTK | 1.0155 | 0.3337 | 0.1585 | 0.0028 | 0.9807 | 0.58582 | 0.99938 |
SUM149PT | Tivantinib | MET | RTK | 0.27624 | -0.2313 | 0.4502 | 0.1850 | 2.3039 | 0.32281 | 0.99937 |
BT-549 | INK-128 | mTORC1/2 | PI3K/mTOR | 0.016573 | 0.0717 | 0.5339 | 0.0484 | 1.5295 | 0.014683 | 0.99934 |
SUM159PT | Saracatinib | SRC | MAPK/nRTK | 13.9057 | 0.5624 | 0.0724 | -0.0011 | 0.9804 | 8.3037 | 0.99931 |
HCC1954 | Trametinib | MEK | MAPK/nRTK | 0.016729 | 0.2287 | 0.4005 | 0.0565 | 0.8524 | 0.0082359 | 0.9993 |
SUM149PT | Vorinostat | HDAC | Misc | 1.3518 | -0.0716 | 0.2279 | 0.0446 | 1.5465 | 1.5699 | 0.9993 |
HCC1937 | Luminespib | HSP90 | Misc | 0.011448 | -0.1867 | 0.5478 | 0.2244 | 4.8554 | 0.012181 | 0.99929 |
HCC1143 | Volasertib | PLK | Cell cycle | 0.0045882 | -0.3453 | 0.7290 | 0.2418 | 1.8336 | 0.005996 | 0.99928 |
SUM159PT | Buparlisib | pan PI3K | PI3K/mTOR | 1.5871 | -0.1942 | 0.2253 | 0.0613 | 1.5281 | 2.1811 | 0.99923 |